CDKN2A and Barrett esophagus: Wang et al. showed that p16 and APC promoter hypermethylation in 17 normal esophagus, 102 BE, and 42 adenocarcinoma patients is reported to be an important marker in dysplastic BE and EAC during a mean follow-up of 4.1 years [30].